CLINICAL_TRIALS
trial_result
· 2022-01-05
Clinical Trial Update: Rate Control in Atrial Fibrillation II [Phase 4]
Summary
Phase 4 clinical trial update on rate control in atrial fibrillation, completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Asker & Baerum Hospital | Conditions: Atrial Fibrillation, Permanent Atrial Fibrillation | Phase 4 | Status: COMPLETED